Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hantel

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Cancer|July 15, 1989
Listeriosis in the setting of malignant disease. Changing issues in an unusual infectionA Hantel, J D Dick, J E Karp
Investigational New Drugs|January 1, 1994
Phase II trial of piroxantrone in gastric carcinoma. A Southwest Oncology Group studyA Hantel, C Tangen, W L Gluck, et al.
Investigational New Drugs|November 1, 1993
A phase II trial of piroxantrone in adenocarcinoma of the pancreas. A Southwest Oncology Group studyT R Jenkins, C Tangen, J S Macdonald, et al.
Investigational New Drugs|May 1, 1993
Phase II trial of piroxantrone in patients with recurrent and metastatic squamous cell carcinoma of the head and neck. A Southwest Oncology Group trialS A Taylor, J Benedetti, D Schuller, et al.
Investigational New Drugs|January 1, 1994
Phase II trial of trimetrexate in untreated advanced gastric carcinoma. A Southwest Oncology Group studyA Hantel, C M Tangen, J S Macdonald, et al.
Investigational New Drugs|November 1, 1989
Assessment of N-methylformamide (NMF) administered orally on a three times weekly schedule: a phase I studyE K Rowinsky, L B Grochow, A Hantel, et al.
Lung Cancer (Amsterdam, Netherlands)|October 27, 2001
Pilot study of sequential vinorelbine and cisplatin followed by docetaxel for selected IIIB and stage IV non-small cell lung cancerJ I Clark, K Kancharla, R Qamar, et al.
Investigational New Drugs|January 1, 1995
A phase II trial of piroxantrone in disseminated malignant melanoma. A Southwest Oncology Group studyJ A Sosman, L E Flaherty, P Y Liu, et al.
Investigational New Drugs|November 1, 1993
Phase II trial of piroxantrone for advanced or metastatic soft tissue sarcomas. A Southwest Oncology Group studyM M Zalupski, J Benedetti, S P Balcerzak, et al.
The Journal of Climate Change and Health|February 6, 2026
Impacts of climate change on cancer risk, clinical outcomes, and care delivery: A scoping reviewD Larios, T Jayakrishnan, M Ioakeim Ioannidou, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Cancer|July 15, 1989
Listeriosis in the setting of malignant disease. Changing issues in an unusual infectionA Hantel, J D Dick, J E Karp
Investigational New Drugs|January 1, 1994
Phase II trial of piroxantrone in gastric carcinoma. A Southwest Oncology Group studyA Hantel, C Tangen, W L Gluck, et al.
Investigational New Drugs|November 1, 1993
A phase II trial of piroxantrone in adenocarcinoma of the pancreas. A Southwest Oncology Group studyT R Jenkins, C Tangen, J S Macdonald, et al.
Investigational New Drugs|May 1, 1993
Phase II trial of piroxantrone in patients with recurrent and metastatic squamous cell carcinoma of the head and neck. A Southwest Oncology Group trialS A Taylor, J Benedetti, D Schuller, et al.
Investigational New Drugs|January 1, 1994
Phase II trial of trimetrexate in untreated advanced gastric carcinoma. A Southwest Oncology Group studyA Hantel, C M Tangen, J S Macdonald, et al.
Investigational New Drugs|November 1, 1989
Assessment of N-methylformamide (NMF) administered orally on a three times weekly schedule: a phase I studyE K Rowinsky, L B Grochow, A Hantel, et al.
Lung Cancer (Amsterdam, Netherlands)|October 27, 2001
Pilot study of sequential vinorelbine and cisplatin followed by docetaxel for selected IIIB and stage IV non-small cell lung cancerJ I Clark, K Kancharla, R Qamar, et al.
Investigational New Drugs|January 1, 1995
A phase II trial of piroxantrone in disseminated malignant melanoma. A Southwest Oncology Group studyJ A Sosman, L E Flaherty, P Y Liu, et al.
Investigational New Drugs|November 1, 1993
Phase II trial of piroxantrone for advanced or metastatic soft tissue sarcomas. A Southwest Oncology Group studyM M Zalupski, J Benedetti, S P Balcerzak, et al.
The Journal of Climate Change and Health|February 6, 2026
Impacts of climate change on cancer risk, clinical outcomes, and care delivery: A scoping reviewD Larios, T Jayakrishnan, M Ioakeim Ioannidou, et al.
Pageof 2